Stem Cell Medicine: Parkinson’s Disease

For questions, or if you are interested in supporting this course and future ISSCR education initiatives, please contact isscr@isscr.org.

This course is supported by educational grants from Novo Nordisk, BlueRock Therapeutics, and Bayer AG.

• About The Course

  This specialized course, developed by the International Society for Stem Cell Research (ISSCR) and accredited by Harvard Medical School, provides a comprehensive exploration of emerging dopamine cell therapy approaches for Parkinson’s disease (PD). Designed for clinicians, medical students, and healthcare professionals, the curriculum is structured into six modules examining the scientific foundations, clinical applications, and future directions of stem cell–based interventions for PD. The course concludes with an interview with a patient who has received a dopamine cell therapy.
  
  Through expert-led lectures, participants gain insight into advanced therapies for PD, the rationale and development of stem cell-based approaches, and the evolving clinical trial landscape. The course promotes responsible clinical practice and aims to prepare clinicians to navigate both the challenges and opportunities of stem cell medicine, with a strong emphasis on patient health and safety.

• Course Features

  • Open access — available to clinicians, medical students, scientists, and the public

  • Accredited — approved for AMA PRA Category 1 Credits™ and American Nurses Credentialing Center (ANCC) contact hours.

• Course Overview

  Organized into six sequential modules:

  1. What is Parkinson’s Disease?

  2. Competing Advanced Therapies for PD

  3. Stem Cells in PD

  4. Evolving Clinical Trial Landscape

  5. Future Adoption of Stem Cell-Based Therapies for PD

  6. PD Patient Perspective: A Conversation with a Stem-PD Trial Participant

• Curriculum Developed By

  • Roger Barker, MRCP, PhD, FMedSci — University of Cambridge, UK

  • Andrew Cassy — STEM-PD Trial, UK

  • Claire Henchcliffe, MD, DPhil, FANA, FAAN — University of California, Irvine, USA

  • Jaime Imitola, MD, FAAN — University of Connecticut School of Medicine, USA

  • Kendra Prutton, PhD — International Society for Stem Cell Research, USA

• Disclosure Document

  View the Disclosure Document

---